肺超声监测间质性肺疾病的表现评估
本研究前瞻性纳入24例间质性肺疾病患者,采用56个肋间隙的肺超声方案在基线、6个月和1年时进行评估,并与高分辨率CT的Warrick评分及肺功能指标进行相关性分析。结果显示肺超声评分与Warrick评分显著相关,且与肺泡容积、一氧化碳弥散量等肺功能指标呈负相关,提示肺超声可能适用于间质性肺疾病的疾病监测。
要点
- 肺超声评分与高分辨率CT的Warrick评分在汇总分析中显著相关(P < .001)。
- 基线(P < .001)和1年(P = .005)时肺超声评分与Warrick评分显著相关。
- 1年时一氧化碳弥散量是一氧化碳弥散量独立预测肺超声评分的因素(P = .026)。
核心结论
- 研究结果强调肺超声在广泛间质性肺疾病疾病监测中的有效性和潜在适用性。
研究设计与样本
- 前瞻性研究,纳入24例间质性肺疾病患者(13例男性,11例女性;平均年龄±标准差,65.4±14.3岁;年龄范围40-84岁),采用56个肋间隙的肺超声方案在侧卧位下于基线、6个月和1年时检查,以高分辨率CT的Warrick评分和肺功能测试为参考。
诊断标准与关键数值
- 肺超声评分定义为各肋间隙计数的B线总和。
- 高分辨率CT按Warrick评分系统分级。
- 汇总数据分析显示Warrick评分与肺超声评分显著相关(P < .001)。
- 基线时肺超声评分与Warrick评分显著相关(P < .001),1年时亦显著相关(P = .005)。
- 6个月时肺超声评分与肺泡容积负相关(P < .046),与一氧化碳弥散量负相关(P < .001);12个月时与一氧化碳弥散量转移系数负相关(P < .031),与一氧化碳弥散量负相关(P = .002)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: In this study, we sought to assess the validity of lung ultrasound (LUS) during the follow-up of patients with a wide spectrum of interstitial lung diseases (ILDs).
METHODS: Twenty-four patients (13 males, 11 females; mean age ± SD, 65.4 ± 14.3 years; age range, 40-84 years) with a diagnosis of ILDs who were admitted to the Interstitial Lung Disease Unit were prospectively enrolled. Patients were examined with a 56-lung intercostal space LUS protocol in lateral decubitus position, at baseline, 6-months, and 1-year. The LUS score was defined as the sum of B-lines counted in each intercostal space. All patients underwent complete pulmonary function tests at baseline and follow-up time-points. High-resolution computed tomography (HRCT) was performed at baseline and during follow-up, according to personalized patients' needs. All HRCT studies were graded according to the Warrick scoring system (WS).
RESULTS: Pooled data analysis showed a significant correlation between WS and LUS scores (P < .001). For separate time-point analysis, a significant correlation between LUS scores and WS was found at baseline (P < .001) and 1 year (P = .005). LUS scores negatively correlated with alveolar volume (VA) (P < .046) and diffusing capacity for carbon monoxide (DLCO) (P < .001) at 6 months and with transfer coefficient of the lung for carbon monoxide (KCO) (P < .031) and DLCO (P = .002) at 12-months. A multivariate regression model showed DLCO to be an independent predictor of LUS score at 1 year (P = .026).
CONCLUSIONS: Our results highlight the validity and potential applicability of LUS for disease monitoring in a wide spectrum of ILDs.
引用
- Pitsidianakis G, Vassalou EE, Vasarmidi E, et al. Performance of Lung Ultrasound for Monitoring Interstitial Lung Disease. J Ultrasound Med. 2021. PMID: 34291845. doi:10.1002/jum.15790
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。